IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 252 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,742,142 | -8.8% | 284,750 | +0.8% | 0.03% | -3.4% |
| Q2 2023 | $3,007,077 | -84.8% | 282,620 | -85.0% | 0.03% | -85.4% |
| Q1 2023 | $19,843,318 | -4.4% | 1,886,247 | +12.6% | 0.20% | -8.7% |
| Q4 2022 | $20,759,309 | +19.4% | 1,675,489 | -0.2% | 0.22% | +10.7% |
| Q3 2022 | $17,386,000 | +1.0% | 1,678,211 | +12.4% | 0.20% | +11.3% |
| Q2 2022 | $17,222,000 | +17.9% | 1,493,637 | +28.7% | 0.18% | +42.7% |
| Q1 2022 | $14,603,000 | +160.4% | 1,160,846 | +141.4% | 0.12% | +195.2% |
| Q4 2021 | $5,607,000 | +23262.5% | 480,849 | +20555.0% | 0.04% | – |
| Q2 2020 | $24,000 | +26.3% | 2,328 | +24.8% | 0.00% | – |
| Q1 2020 | $19,000 | – | 1,865 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |